Bladder Cancer
Kidney Cancer
EAU Edu Platform on Prostate Cancer
Home
Articles
Article of the Month
Editorial
Videos
Webcasts
Education
Curriculum: mPCa patients treatment
Curriculum: CVD risk in PCa patients
E-courses
ESOU Online
Webinars
Guidelines
Events
Home
Articles
Terug
Article of the Month
Editorial
Videos
Webcasts
Education
Terug
Curriculum: mPCa patients treatment
Curriculum: CVD risk in PCa patients
E-courses
ESOU Online
Webinars
Guidelines
Events
Upcoming event
40th Annual EAU Congress
Home
/
Videos
Back
UROonco24
EAU24
EAU23
ASCO GU23
EMUC2022
ESMO2022
EAU22
ASCO22
ASCO GU22
EMUC21
EAU 21
ASCO GU21
EAU20
ESOU Online
ASCO19
EAU19
GU19
EMUC 2018
EMUC 2014
ESMO 2014
ERUS 2014
Filter
Tags
Abiraterone
,
Active surveillance
,
Adjuvant
,
ADT
,
Advanced prostate cancer
,
Alkaline phosphatase
,
Alternative splicing
,
Androgen
,
Androgen deprivation therapy
,
Androgen pathway blockade
,
Androgen receptor inhibitor
,
Antiandrogens
,
Anticancer agents
,
ARCHES
,
Article of the Month
,
ASCO GU21
,
ASCO GU22
,
ASCO21
,
AUA21
,
BHC80
,
Biochemical recurrence
,
Biomarkers
,
Biopsy
,
Bisphosphonates
,
Bone metastases
,
BRCA1
,
BRCA2
,
Castrate-resistanter
,
Castration-resistant
,
Chemotherapy
,
Clinical trial
,
Clinical trials
,
Cohort study
,
COVID-19
,
cSP
,
Deferred treatment
,
Diagnosis
,
Disease progression
,
Docetaxel
,
EAU21
,
EAU22
,
Emission-computed
,
EMUC21
,
EMUC22
,
End-to-side nerve grafting
,
Enzalutamide
,
Erectile dysfunction
,
Erectile function
,
ESMO21
,
ESMO22
,
ESOU Online
,
ESU Masterclass
,
ESU Masterclasses
,
External beam radiotherapy
,
Focal therapy
,
Frozen section
,
Fusion biopsies
,
Genomic classifier
,
Genomics
,
Guidelines
,
hormone-sensitive
,
HORRAD
,
HRQL
,
Image guided biopsy
,
Imaging
,
Immunohistochemistry
,
Index lesion
,
Indocyanine green
,
Intensity-modulated radiotherapy
,
Local radiotherapy
,
Localised
,
Localized
,
Localized prostate cancer
,
Lymph node excision
,
Lymphadenectomy
,
Mapping
,
Mass spectrometry
,
Masterclass
,
Masterclasses
,
MDV3100
,
Membranous urethra
,
Meta-analysis
,
Metastasis
,
Metastasized
,
Metastatic
,
Mortality reduction
,
mp-MRI
,
MRI
,
Neoplasm staging
,
Nerve sparing
,
Next-generation sequencing
,
Nomogram
,
Noncastrate
,
Orchiectomy
,
Overdiagnosis
,
p53
,
Patient information
,
PCa21
,
Penile rehabilitation
,
PET/CT
,
Positron emission tomography
,
Precision medicine
,
Pretreatment risk stratification
,
Pretreatment tables
,
Primary tumor treatment
,
Prognosis
,
Prognostic model
,
Prostasomes
,
Prostate screening
,
Prostate-specific antigen
,
Prostate-specific membrane antigen
,
Prostatic neoplasms
,
ProtecT trial
,
Proteomics
,
PSA
,
PSA flare
,
PSA kinetics
,
PSA screening
,
PSMA PET/CT
,
PTEN
,
Quality of life
,
Radiation therapy
,
Radical prostatectomy
,
Randomized prospective trial
,
Randomized trial
,
Randomized trials
,
Rapid metastasis
,
Rb
,
RB1
,
Receptors
,
Risk stratification
,
RNA splicing
,
Robotic prostatectomy
,
Robotic surgery
,
Robotic Urology
,
Robotics
,
Salvage therapy
,
Screening
,
Sentinel lymph node
,
Sexual quality of life
,
SREs
,
SRRM4
,
STAMPEDE
,
Stereotactic body radiotherapy
,
Surgical margins
,
Surgical video
,
Surgical videos
,
Systematic biopsy
,
Systematic review
,
Targeted Biopsy
,
TITAN
,
TP53
,
Transcriptome
,
Transperineal template biopsy
,
Tumor suppressor genes
,
Ultrasensitive PSA
,
Urinary incontinence
,
Urological surgery
,
Urowebinar
,
WCRF/AICR CUP
,
Webinar
,
Wnt
,
Zoledronic acid
Show all
Increased risk of urological cancer
Watch now
Previous